Perspectives on human perinatal renal tract disease

Seminars in Fetal and Neonatal Medicine

Volumn 13, Issue 3, 2008, Pages 196-201

  Woolf, Adrian S ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Genes; Mutations; Prognosis; Renal failure; Therapy

Indexed keywords

ARTICLE; CLINICAL TRIAL; DECOMPRESSION SURGERY; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE SEVERITY; GENE MUTATION; HUMAN; HYDRONEPHROSIS; HYPERTENSION; KIDNEY CYST; KIDNEY FAILURE; KIDNEY FUNCTION; MORBIDITY; NONHUMAN; OUTCOME ASSESSMENT; PERINATAL MORBIDITY; PROSPECTIVE STUDY; PRUNE BELLY SYNDROME; SHUNTING; SURVIVAL; URINARY TRACT DISEASE; URINARY TRACT MALFORMATION; VESICOURETERAL REFLUX;

CHILD; FETAL DISEASES; HUMANS; INFANT, NEWBORN; KIDNEY; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; PROGNOSIS;

EID: 41549122752     PISSN: 1744165X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.siny.2007.10.001     Document Type: Article

References (59)

1. Lewis M.A. Demography of renal disease in childhood. Semin Fetal Neonat Med 13 3 (2008) 118-124
2. Abbott J.F., Levine D., and Wapner R. Posterior urethral valves: inaccuracy of prenatal diagnosis. Fetal Diagn Ther 13 (1998) 179-183
3. Yiee J., and Wilcox D. Abnormalities of the fetal bladder. Semin Fetal Neonatal Med 13 3 (2008) 164-170
4. Rees L. Management of the neonate with chronic renal failure. Semin Fetal Neonatal Med 13 3 (2008) 181-188
5. Adeva M., El-Youssef M., Rossetti S., et al. Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD). Medicine (Baltimore) 85 (2006) 1-21
6. Zingg-Schenk A., Bacchetta J., Corvol P., et al. Inherited renal tubular dysgenesis: the first patients surviving the neonatal period. Eur J Pediatr (2007 Apr 19) PMID:17443344
7. Klaassen I., Neuhaus T.J., Mueller-Wiefel D.E., and Kemper M.J. Antenatal oligohydramnios of renal origin: long-term outcome. Nephrol Dial Transplant 22 (2007) 432-439
8. Thomas D.F.M. Prenatally diagnosed urinary tract abnormalities: long term out come. Semin Fetal Neonatal Med 13 3 (2008) 189-195
9. Woolf A.S., and Hillman K.A. Unilateral renal agenesis and the congenital solitary functioning kidney: developmental, genetic and clinical perspectives. BJU Int 99 (2007) 17-21
10. Woolf A.S. Unilateral multicystic dysplastic kidney. Kidney Int 69 (2006) 190-193
11. Argueso L.R., Ritchey M.L., Boyle Jr. E.T., Milliner S.D., Bergstralh E.J., and Kramer S.A. Prognosis of patients with unilateral renal agenesis. Pediatr Nephrol 6 (1992) 412-416
12. Gonzalez E., Gutierrez E., Morales E., et al. Factors influencing progression of renal damage in patients with unilateral renal agenesis and remnant kidney. Kidney Int 68 (2005) 263-270
13. Rodríguez M.M., Gómez A.H., Abitbol C.L., Chandar J.J., Duara S., and Zilleruelo G.E. Histomorphometric analysis of postnatal glomerulogenesis in extremely preterm infants. Pediatr Dev Pathol 7 (2004) 17-25
14. Kist-van Holthe J.E., van Zwieten P.H., Schell-Feith E.A., et al. Is nephrocalcinosis in preterm neonates harmful for long-term blood pressure and renal function?. Pediatrics 119 (2007) 468-475
15. Schmidt I.M., Chellakooty M., Boisen K.A., et al. Impaired kidney growth in low-birth-weight children: distinct effects of maturity and weight for gestational age. Kidney Int 68 (2005) 731-740
16. Keller G., Zimmer G., Mall G., Ritz E., and Amann K. Nephron number in patients with primary hypertension. N Engl J Med 348 (2003) 101-108
17. Clark T.J., Martin W.L., Divakaran T.G., Whittle M.J., Kilby M.D., and Khan K.S. Prenatal bladder drainage in the management of fetal lower urinary tract obstruction: a systematic review and meta-analysis. Obstet Gynecol 102 (2003) 367-382
18. Ylinen E., Ala-Houhala M., and Wikstrom S. Prognostic factors of posterior urethral valves and the role of antenatal detection. Pediatr Nephrol 19 (2004) 874-879
19. Kilby M., Khan K., et al., Pluto Collaborative Study Group. PLUTO trial protocol: percutaneous shunting for lower urinary tract obstruction randomised controlled trial. BJOG 114 (2007) 904-905 e1-4
20. Farrugia M.K., Long D.A., Godley M.L., et al. Experimental short-term fetal bladder outflow obstruction. I. Morphology and cell biology associated with urinary flow impairment. J Pediatr Urol 2 (2006) 243-253
21. Ylinen E., Ala-Houhala M., and Wikstrom S. Outcome of patients with antenatally detected pelviureteric junction obstruction. Pediatr Nephrol 19 (2004) 880-887
22. Decramer S., Wittke S., Mischak F., et al. Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis. Nat Med 12 (2006) 398-400
23. Craig J.C., Irwig L.M., Knight J.F., and Roy L.P. Does treatment of vesicoureteric reflux prevent end-stage renal disease attributable to reflux nephropathy?. Pediatrics 105 (2000) 1236-1241
24. Smellie J., Barratt T.M., Chantler C., et al. Medical versus surgical treatment in children with severe bilateral vesicoureteric reflux and bilateral nephropathy: a randomised trial. Lancet 357 (2001) 1329-1333
25. Hodson E., Wheeler D., Vimalchandra D., Smith G., and Craig J. Interventions for primary vesicoureteric reflux. Cochrane Database Syst Rev 3 (2007) CD001532
26. Gordon I., Barkovics M., Pindoria S., Cole T.J., and Woolf A.S. Primary vesicoureteric reflux as a predictor of renal damage in children hospitalized with urinary tract infection: a systematic review and meta-analysis. J Am Soc Nephrol 14 (2003) 739-744
27. Neild G.H., Thomson G., Nitsch D., Woolfson R.G., Connolly J.O., and Woodhouse C.R. Renal outcome in adults with renal insufficiency and irregular asymmetric kidneys. BMC Nephrol 5 (2004) 12
28. Wühl E., Mehls O., Schaefer F., and ESCAPE Trial Group. Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure. Kidney Int 66 (2004) 768-776
29. Ardissino G., Viganò S., Testa S., et al., on behalf of the ItalKid Project. No clear evidence of ACEi efficacy on the progression of chronic kidney disease in children with hypodysplastic nephropathy report from the ItalKid project database. Nephrol Dial Transplant 22 (2007) 2525-2530
30. Woolf A.S., Price K.L., Scambler P.J., and Winyard P.J. Evolving concepts in human renal dysplasia. J Am Soc Nephrol 15 (2004) 998-1007
31. Jain S., Suarez A.A., McGuire J., and Liapis H. Expression profiles of congenital renal dysplasia reveal new insights into renal development and disease. Pediatr Nephrol 22 (2007) 962-974
32. Yang S.P., Woolf A.S., Yuan H.T., et al. Potential biological role of transforming growth factor β1 in human congenital kidney malformations. Am J Pathol 157 (2000) 1633-1647
33. Dekel B., Amariglio N., Kaminski N., et al. Engraftment and differentiation of human metanephroi into functional mature nephrons after transplantation into mice is accompanied by a profile of gene expression similar to normal human kidney development. J Am Soc Nephrol 13 (2002) 977-990
34. Atala A., Bauer S.B., Soker S., Yoo J.J., and Retik A.B. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 367 (2006) 1241-1246
35. Woo D.D.L., Miao S., Pelayo J., and Woolf A.S. Taxol inhibits progression of congenital polycystic kidney disease. Nature 368 (1994) 750-753
36. Gattone II V.H., Wang X., Harris P.C., and Torres V.E. Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nat Med 9 (2003) 1323-1326
37. Potter E.L. Normal and abnormal development of the kidney (1972), Year Book Medical Publishers, Chicago p. 1-305
38. Rossetti S., Consugar M.B., Chapman A.B., et al., CRISP Consortium. Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 18 (2007) 2143-2160
39. Rosenblum N.D. Developmental biology of the human kidney. Semin Fetal Neonatal Med 13 3 (2008) 125-132
40. Deshpande C., and Hennekam R.C.M. Genetic syndromes and prenatally detected renal anomalies. Semin Fetal Neonatal Med 13 3 (2008) 171-180
41. Kolatsi-Joannou M., Bingham C., Ellard S., et al. Hepatocyte nuclear factor 1β: a new kindred with renal cysts and diabetes, and gene expression in normal human development. J Am Soc Nephrol 12 (2001) 2175-2180
42. Bingham C., Ellard S., Cole T.R., et al. Solitary functioning kidney and diverse genital tract malformations associated with hepatocyte nuclear factor-1β mutations. Kidney Int 61 (2002) 1243-1251
43. Weber S., Moriniere V., Knuppel T., et al. Prevalence of mutations in renal developmental genes in children with renal hypodysplasia: results of the ESCAPE study. J Am Soc Nephrol 17 (2006) 2864-2870
44. Decramer S., Parant O., Beaufils S., et al. Anomalies of the TCF2 gene are the main cause of fetal bilateral hyperechogenic kidneys. J Am Soc Nephrol 18 (2007) 923-933
45. Salomon R., Tellier A.L., Attie-Bitach T., et al. PAX2 mutations in oligomeganephronia. Kidney Int 59 (2001) 457-462
46. Quinlan J., Lemire M., Hudson T., et al. A common variant of the PAX2 gene is associated with reduced newborn kidney size. J Am Soc Nephrol 18 (2007) 1915-1921
47. Welham S.J.M., Wade A., and Woolf A.S. Protein restriction in pregnancy is associated with increased apoptosis of mesenchymal cells at the start of rat metanephrogenesis. Kidney Int 61 (2002) 1231-1242
48. Lacoste M., Cai Y., Guicharnaud L., et al. Renal tubular dysgenesis, a not uncommon autosomal recessive disorder leading to oligohydramnios: role of the renin-angiotensin system. J Am Soc Nephrol 17 (2006) 2253-2263
49. Cooper W.O., Hernandez-Diaz S., Arbogast P.G., et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 354 (2006) 2443-2451
50. Centers for Disease Control and Prevention (CDC). Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy - United States, Canada, and Israel, 1987-1995. MMWR Morb Mortal Wkly Rep 46 (1997) 240-242
51. McGregor L., Makela V., Darling S.M., et al. Fraser syndrome and mouse blebbed phenotype caused by mutations in FRAS1/Fras1 encoding a putative extracellular matrix protein. Nat Genet 34 (2003) 203-208
52. Jadeja S., Smyth I., Pitera J.E., et al. Identification of a new gene mutated in Fraser syndrome and mouse myelencephalic blebs. Nat Genet 37 (2005) 520-525
53. Karmous-Benailly H., Martinovic J., Gubler M.C., et al. Antenatal presentation of Bardet-Biedl syndrome may mimic Meckel syndrome. Am J Hum Genet 76 (2005) 493-504
54. Ickowicz V., Eurin D., Maugey-Laulom B., et al. Meckel-Gruber syndrome: sonography and pathology. Ultrasound Obstet Gynecol 27 (2006) 296-300
55. Baala L., Romano S., Khaddour R., et al. The Meckel-Gruber syndrome gene, MKS3, is mutated in Joubert syndrome. Am J Hum Genet 80 (2007) 186-194
56. Consugar M.B., Kulby V.J., Lager D.J., et al. Molecular diagnostics of Meckel-Gruber syndrome highlights phenotypic differences between MKS1 and MKS3. Hum Genet 121 (2007) 591-599
57. Jenkins D., and Woolf A.S. Uroplakins: new molecular players in the biology of urinary tract malformations. Kidney Int 71 (2007) 195-200
58. Lu W., van Eerde A.M., Fan X., et al. Disruption of ROBO2 is associated with congenital anomalies of kidney and urinary tract and confers risk of vesicoureteric reflux. Am J Hum Genet 80 (2007) 616-632
59. Weber S., Mir S., Schlingmann K.P., et al. Gene locus ambiguity in posterior urethral valves/prune-belly syndrome. Pediatr Nephrol 20 (2005) 1036-1042